Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
Health Information Technology for Economic and Clinical Health (HITECH) Penalties and Enforcement Use and Disclosure of PHI; Right to Access
Health Insurance Portability and Accountability Act (HIPAA) acknowledgment of notice business associates FTC and FCC regulations health information technology (HIT) infrastructure health information use and disclosure Health Insurance Portability and Accountability Act of 1996 notice provision penalties and enforcement policies and procedures privacy abuses, examples of protected health information training programs use and disclosure of PHI
See durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) Medicare Medicare Part D See durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS)
Docken v. Ciba-Geigy (1987)
doctrine of negligence per se
documentation
Donabedian, Avedis
dosage information, labels directions for use State Regulation of Third-Party Plans
doughnut hole, Medicare Part D
Douglas v. Independent Living Center of Southern California, Inc. (2012)
draft compliance guides
See drug regimen review (DRR) Drug Regimen Review (Consultant Pharmacist) Federal Regulation of Long-Term Care Harder v. F. C. Clinton, Inc. See drug regimen review (DRR)
drug abuse policy
Drug Addiction Treatment Act of 2000 Issuance of Prescriptions Purpose of a Controlled Substance Prescription Treatment of Addicts Outside of OTPs
Drug Competition Action Plan
Drug Efficacy Amendment (1962)
Drug Efficacy Study Implementation (DESI)
Drug Enforcement Administration (DEA) hospital pharmacy regulations laws made by Licensing of Pharmacies opioid treatment programs Pharmacist's Guide to Prescription Fraud Pharmacist's Manual (2010) pharmacy inspections and Prospective Drug Utilization Review registration number regulation of pharmacy in hospitals returns of controlled substances State Regulation of Third-Party Plans State vs Federal Authority
drug formularies
drug information website Drug Information Website for Pharmacists: Drug Info Rounds for consumers and health professionals for pharmacists
Drug Info Rounds
Drug Price Competition and Patent Term Restoration Act (PTRA) of 1984 drug manufacturer controversial practices Drug Price Competition and Patent Term Restoration Act of 1984 generic drug labeling controversies healthcare practitioners controversies Importance of the Orange Book in Generic Substitution section 505(b)(2) NDAs The Generic Drug Enforcement Act of 1992
drug product liability defects Drug Product Liability duty to warn labeling and liability overview pharmacists and
Drug Quality and Security Act of 2013 (DQSA)
drug recalls
drug regimen review (DRR) Harder v. F. C. Clinton, Inc. Labeling of Drugs and Biologicals
drug-related cases, causation in
drug supply chain
Drug Supply Chain Security Act (DSCSA) of 2013
drugs